| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $38K | — |
| Cost of Revenue | $19K | — |
| Gross Profit | $19K | — |
| R&D Expense | $625K | +163.0% |
| SG&A Expense | $2.2M | -92.6% |
| Operating Income | -$2.8M | +90.6% |
| Interest Expense | $17K | -92.5% |
| Income Tax | $0 | — |
| Net Income | -$1.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13K | -38.6% |
| Inventory | $35K | — |
| Current Assets | $71K | +165.1% |
| Total Assets | $351K | +1208.0% |
| Current Liabilities | $2.4M | +106.7% |
| Total Liabilities | $2.4M | +106.7% |
| Stockholders' Equity | -$2.1M | -80.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$620K | +25.2% |
| Investing Cash Flow | -$41K | — |
| Financing Cash Flow | $652K | -18.9% |